← Back to headlines





Samsung Biologics and Eli Lilly Partner to Build Biotech Innovation Hub in Korea
Samsung Biologics has partnered with Eli Lilly to establish an open innovation hub for emerging biotechnology companies in Korea, marking Eli Lilly's first such site outside the United States and China.
11 Mar, 05:10 — 11 Mar, 05:10
Related Stories

Homeland Security Secretary’s Plane Makes Emergency Landing After Engine Failure
29m ago
Berkshire Hathaway Signals Long-Term Commitment to Japanese Trading Houses
38m ago
South Korean Utility Proposes $15 Billion Upfront Power Payment From Samsung
1h ago
Chevron Confirms Expansion of Oil Operations in Venezuela
1h ago